2.02
-0.09(-4.27%)
Currency In USD
| Previous Close | 2.11 |
| Open | 2.1 |
| Day High | 2.1 |
| Day Low | 2 |
| 52-Week High | 9.19 |
| 52-Week Low | 1.83 |
| Volume | 190,616 |
| Average Volume | 1.55M |
| Market Cap | 17.88M |
| PE | -0.94 |
| EPS | -2.16 |
| Moving Average 50 Days | 2.55 |
| Moving Average 200 Days | 3.01 |
| Change | -0.09 |
If you invested $1000 in Daré Bioscience, Inc. (DARE) 10 years ago, it would be worth $5.01 as of August 20, 2025 at a share price of $2.02. Whereas If you bought $1000 worth of Daré Bioscience, Inc. (DARE) shares 5 years ago, it would be worth $142.66 as of August 20, 2025 at a share price of $2.02.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Daré Bioscience to Host Second Quarter 2025 Financial Results and Company Update Conference Call and Webcast on August 14, 2025
GlobeNewswire Inc.
Aug 07, 2025 12:00 PM GMT
SAN DIEGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a biopharmaceutical company with a sole focus of closing the gap in women’s health between promising science and real solutions, will host a conference call and li
Daré Bioscience and Rosy Wellness Launch First Phase of Patient-Focused Campaign to Support DARE to PLAY™ Sildenafil Cream
GlobeNewswire Inc.
Jul 29, 2025 12:00 PM GMT
A first-of-its-kind solution for women’s arousal in a proprietary topical formulation demonstrated to work where women need it most Targeted to be available by prescription in the fourth quarter of 2025 Collaboration leverages Rosy Wellness’ extensiv
UPDATE - Daré Bioscience to Host August 6 Webinar: The DARE to PLAY™ Difference - The Sildenafil Cream That Raises the Bar
GlobeNewswire Inc.
Jul 21, 2025 5:47 PM GMT
A first-of-its-kind solution for women’s arousal - the same active ingredient as in Viagra® for men - in a proprietary topical formulation demonstrated to work where women need it most Targeted to be available by prescription in the fourth quarter of